93 related articles for article (PubMed ID: 25259545)
1. Role of corticosteroids for fatigue in advanced incurable cancer: is it a 'wonder drug' or 'deal with the devil'.
Yennurajalingam S; Bruera E
Curr Opin Support Palliat Care; 2014 Dec; 8(4):346-51. PubMed ID: 25259545
[TBL] [Abstract][Full Text] [Related]
2. Physician-reported corticosteroid therapy practices in certified palliative care units in Japan: a nationwide survey.
Matsuo N; Morita T; Iwase S
J Palliat Med; 2012 Sep; 15(9):1011-6; quiz 117-8. PubMed ID: 22734663
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Delirium in Corticosteroid-Treated Patients with Advanced Cancer: An Exploratory, Multicenter, Prospective, Observational Study.
Matsuo N; Morita T; Matsuda Y; Okamoto K; Matsumoto Y; Kaneishi K; Odagiri T; Sakurai H; Katayama H; Mori I; Yamada H; Watanabe H; Yokoyama T; Yamaguchi T; Nishi T; Shirado A; Hiramoto S; Watanabe T; Kohara H; Shimoyama S; Aruga E; Baba M; Sumita K; Iwase S
J Palliat Med; 2017 Apr; 20(4):352-359. PubMed ID: 28379811
[TBL] [Abstract][Full Text] [Related]
4. The use of corticosteroids in reducing cancer-related fatigue: assessing the evidence for clinical practice.
Begley S; Rose K; O'Connor M
Int J Palliat Nurs; 2016 Jan; 22(1):5-9. PubMed ID: 26804950
[TBL] [Abstract][Full Text] [Related]
5. Anorexia and cachexia in advanced cancer patients.
Vigano A; Watanabe S; Bruera E
Cancer Surv; 1994; 21():99-115. PubMed ID: 8565002
[TBL] [Abstract][Full Text] [Related]
6. Do Patients Benefit from a Trial of Corticosteroids at the End of Life?
Yennurajalingam S; Bruera E
Curr Treat Options Oncol; 2022 Jun; 23(6):796-805. PubMed ID: 35362799
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of the treatment of cancer-associated anorexia and weight loss.
Yavuzsen T; Davis MP; Walsh D; LeGrand S; Lagman R
J Clin Oncol; 2005 Nov; 23(33):8500-11. PubMed ID: 16293879
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Responses to Corticosteroids for Cancer-Related Fatigue in Advanced Cancer Patients: A Multicenter, Prospective, Observational Study.
Matsuo N; Morita T; Matsuda Y; Okamoto K; Matsumoto Y; Kaneishi K; Odagiri T; Sakurai H; Katayama H; Mori I; Yamada H; Watanabe H; Yokoyama T; Yamaguchi T; Nishi T; Shirado A; Hiramoto S; Watanabe T; Kohara H; Shimoyama S; Aruga E; Baba M; Sumita K; Iwase S
J Pain Symptom Manage; 2016 Jul; 52(1):64-72. PubMed ID: 27233138
[TBL] [Abstract][Full Text] [Related]
9. [Recent development in research and management of cancer anorexia-cachexia syndrome].
Inui A
Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
[TBL] [Abstract][Full Text] [Related]
10. The risks and benefits of corticosteroids in advanced cancer.
Twycross R
Drug Saf; 1994 Sep; 11(3):163-78. PubMed ID: 7811399
[TBL] [Abstract][Full Text] [Related]
11. Review of clinical trials of pharmacologic interventions for cancer-related fatigue: focus on psychostimulants and steroids.
Yennurajalingam S; Bruera E
Cancer J; 2014; 20(5):319-24. PubMed ID: 25299141
[TBL] [Abstract][Full Text] [Related]
12. Role of corticosteroids in palliative care.
Shih A; Jackson KC
J Pain Palliat Care Pharmacother; 2007; 21(4):69-76. PubMed ID: 18032321
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of modafinil in the treatment of cancer-related fatigue.
Cooper MR; Bird HM; Steinberg M
Ann Pharmacother; 2009 Apr; 43(4):721-5. PubMed ID: 19318599
[TBL] [Abstract][Full Text] [Related]
14. Predictors of responses to corticosteroids for anorexia in advanced cancer patients: a multicenter prospective observational study.
Matsuo N; Morita T; Matsuda Y; Okamoto K; Matsumoto Y; Kaneishi K; Odagiri T; Sakurai H; Katayama H; Mori I; Yamada H; Watanabe H; Yokoyama T; Yamaguchi T; Nishi T; Shirado A; Hiramoto S; Watanabe T; Kohara H; Shimoyama S; Aruga E; Baba M; Sumita K; Iwase S
Support Care Cancer; 2017 Jan; 25(1):41-50. PubMed ID: 27539132
[TBL] [Abstract][Full Text] [Related]
15. The impact of early and brief corticosteroids on the clinical course of primary pulmonary coccidioidomycosis.
Azadeh N; Chang YH; Kusne S; Vikram HR; Seville MT; Orenstein R; Blair JE
J Infect; 2013 Aug; 67(2):148-55. PubMed ID: 23570823
[TBL] [Abstract][Full Text] [Related]
16. Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials.
Ferro M; Di Lorenzo G; de Cobelli O; Bruzzese D; Pignataro P; Borghesi M; Musi G; Vartolomei MD; Cosimato V; Serino A; Ieluzzi V; Terracciano D; Damiano R; Cantiello F; Mistretta FA; Muto M; Lucarelli G; De Placido P; Buonerba C
World J Urol; 2019 Jun; 37(6):1049-1059. PubMed ID: 30519742
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Optimal Time for Starting Betamethasone Using Fatigue Scores and Prognostic Nutritional Index in Terminally Ill Patients With Cancer-Related Fatigue.
Koyama N; Matsumura C; Morii H; Hasegawa C; Hira D; Daigo Y; Terada T; Yano Y
Am J Hosp Palliat Care; 2017 Jun; 34(5):449-455. PubMed ID: 26888884
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and undesirable effects of corticosteroid therapy experienced by palliative care specialists in Japan: a nationwide survey.
Matsuo N; Morita T; Iwase S
J Palliat Med; 2011 Jul; 14(7):840-5. PubMed ID: 21631371
[TBL] [Abstract][Full Text] [Related]
19. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review).
Strang P
Anticancer Res; 1997; 17(1B):657-62. PubMed ID: 9066597
[TBL] [Abstract][Full Text] [Related]
20. Use of corticosteroids for anorexia in palliative medicine: a systematic review.
Miller S; McNutt L; McCann MA; McCorry N
J Palliat Med; 2014 Apr; 17(4):482-5. PubMed ID: 24702642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
